China's M&A Controls Shown In Pfizer Sale Of Unit To China Firm
This article was originally published in PharmAsia News
Executive Summary
China's government influence over foreign mergers and acquisition was highlighted when U.S.-based Pfizer sold its swine-vaccine unit to a Chinese company